Spyre Therapeutics Inc.: Rising -21.35% from 52-Week Low, Can the Stock Stay Afloat?

In terms of market performance, Spyre Therapeutics Inc. had a somewhat regular. The highest value for the stock in the past year was $28.66 on 01/23/24, while the lowest value was $2.66 on 06/21/23.

52-week price history of SYRE Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Spyre Therapeutics Inc.’s current trading price is -21.35% away from its 52-week high, while its distance from the 52-week low is 747.37%. The stock’s price range for this period has remained between $2.66 and $28.66. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.53 million for the day, which was noticeably higher compared to the shares’ average daily volume of 2.53 over the last three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Financial Performance and Market Capitalization

Spyre Therapeutics Inc. (SYRE) has experienced a quarterly rise of 138.01% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 812.79M.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 16.63, with a change in price of +10.53. Similarly, Spyre Therapeutics Inc. recorded 147,793 in trading volume during the last 100 days, posting a change of +87.68%.

SYRE Stock Stochastic Average

As of today, the raw stochastic average of Spyre Therapeutics Inc. over the past 50 days is 57.62%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 25.00%. Additionally, the Stochastic %K and %D values for the company were 35.90% and 42.39%, respectively, over the past 20 days.

SYRE Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 4.74% this year. Over the last six months, there has been a weaker performance of 80.32%. The price of SYRE fallen by 7.38% during the last 30 days period. For the last 5-days stocks have slided -10.94%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts